Publication - Consultation paper
Renal Cancer Clinical Quality Performance Indicators: Engagement Document
This document is being circulated for comment and feedback in order to ensure wide
engagement with professional groups, health service staff, voluntary organisations, patients affected by renal cancer and the wider public.
Footnotes
1. Active treatment is defined as partial or radical
nephrectomy, cryotherapy, radio frequency ablation or systemic
therapy
2. Valid prognostic scoring can be assigned using various
models including MSKCC/Motzer, or Heng scoring tools.
3. Advanced/ metastatic disease defined as T4NanyMany;
TanyNanyM1.
4. Systemic anti-cancer treatments will include any drug
which is licensed in this indication; the accompanying data
standard contains relevant information about appropriate
treatments.